Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide
The Journal of Dermatology · 2023-04 · 50 (4) · 445-452
DOI: 10.1111/1346-8138.16690 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 28.12.2022. Verfasst von Debby Wensink und 3 weiteren Autor:innen. Beteiligte Einrichtung: Porphyria Expertcenter Rotterdam, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, Erasmus University Medical…. Hauptthemen laut MEDLINE: Protoporphyria, Erythropoietic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Erythropoietic protoporphyria (EPP) patients experience severe burning pain after light exposure, which results in a markedly reduced quality of life. However, there is limited information on the psychosocial aspects of EPP. To investigate the clinical features and social aspects of living with EPP, before and during afamelanotide treatment in the Netherlands. A single‐center prospective longitudinal study of adult patients with EPP attending the Erasmus MC Rotterdam. Patients completed questionnaires, comprising demographic, clinical and social details, including two generic (DS‐14 and SF‐36) and a disease specific (EPP‐QoL) QoL questionnaires. 121 adult EPP patients were included. The educational level of EPP patients seemed higher compared to the Dutch population (36% vs. 30% high‐education, 42% vs. 37% middle‐education). At baseline 5% of the EPP patients were unemployed, none were unemployed during afamelanotide treatment. Full‐ and part‐time employment rate increased from 59.5% to 69.9% on afamelanotide treatment ( p > 0.05). EPP‐QoL improved from 44% to 75% on afamelanotide treatment ( p < 0.001). Type‐D personality was present in 27.4% of patients; their social inhibition scores improved significantly on afamelanotide treatment ( p = 0.019). EPP patients scored low on the social functioning domain (SF‐36) compared to the Dutch population (74.4 ± 27.3 vs. 84.0 ± 22.4; respectively), and improved during afamelanotide treatment (84.3 ± 20.9, p = 0.001). EPP has a significant negative impact on social aspects, with less employment despite a higher education level. Afamelanotide treatment improves quality of life, social functioning and possibly employment rate. It is important to recognize the impact of EPP on social life, although, more research is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Porphyria Expertcenter Rotterdam, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
ORCID-Profile: Debby Wensink, Margreet A E M Wagenmakers, J H Paul Wilson, Janneke G Langendonk
Zitieren
APA
Wensink, D., Wagenmakers, M. A. E. M., Wilson, J. H. P., & Langendonk, J. G. (2023). Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide. The Journal of Dermatology, 50(4), 445-452. https://doi.org/10.1111/1346-8138.16690
Vancouver
Wensink D, Wagenmakers MAEM, Wilson JHP, Langendonk JG. Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide. The Journal of Dermatology. 2023;50(4):445-452. doi:10.1111/1346-8138.16690
BibTeX
@article{Wensink2023,
author = {Wensink, Debby and Wagenmakers, Margreet A E M and Wilson, J H Paul and Langendonk, Janneke G},
title = {Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide},
journal = {The Journal of Dermatology},
year = {2023},
volume = {50},
number = {4},
pages = {445--452},
doi = {10.1111/1346-8138.16690}
}
EUVIMED